Research
Ocular Manifestations in Juvenile Behçet's Disease: A Registry-Based Analysis
A recent study sheds light on the ocular manifestations of Behçet's disease in pediatric patients, filling a critical gap in understanding this relatively uncommon condition in children.
Link to article
The study, drawing from a large international cohort from the AIDA Network Behçet's disease registry, aimed to provide a comprehensive characterization of ocular manifestations in pediatric Behçet's disease. One of the key findings revealed that approximately 40% of patients with juvenile Behçet's disease (jBD) experience ocular inflammation, with only 13% manifesting ocular symptoms before the age of 18. This finding underscores the variability in reported prevalence rates of ocular jBD in existing literature.
Age and gender emerged as influential factors in determining both the timing of onset and the anatomical location of ocular inflammation. Furthermore, the study highlighted the potential existence of a subset of pediatric patients with early-onset jBD facing a poorer overall and ocular prognosis. Notably, the presence of HLA-B51 was identified as a predictor of decreased final visual acuity in children with jBD, suggesting a potential marker for prognosis assessment.
Given the rarity of Behçet's disease in children and the focused nature of the study, the insights gleaned from this analysis hold significant implications for clinical practice and future research endeavors.